Splenic rupture after granulocyte-colony-stimulating factor mobilization in a peripheral blood progenitor cell donor - PubMed

Case Reports

Splenic rupture after granulocyte-colony-stimulating factor mobilization in a peripheral blood progenitor cell donor

Humbelina Balaguer et al. Transfusion. 2004 Aug.

Similar articles

• Splenic rupture in a patient with plasma cell myeloma following G-CSF/GM-CSF administration for stem cell transplantation and review of the literature.

  Veerappan R, Morrison M, Williams S, Variakojis D. Veerappan R, et al. Bone Marrow Transplant. 2007 Aug;40(4):361-4. doi: 10.1038/sj.bmt.1705736. Epub 2007 Jun 11. Bone Marrow Transplant. 2007. PMID: 17563733 Review.

• Splenic rupture in a parental donor undergoing peripheral blood progenitor cell mobilization.

  Dincer AP, Gottschall J, Margolis DA. Dincer AP, et al. J Pediatr Hematol Oncol. 2004 Nov;26(11):761-3. doi: 10.1097/00043426-200411000-00015. J Pediatr Hematol Oncol. 2004. PMID: 15543014

• Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.

  de la Rubia J, de Arriba F, Arbona C, Pascual MJ, Zamora C, Insunza A, Martínez D, Paniagua C, Díaz MA, Sanz MA. de la Rubia J, et al. Haematologica. 2008 May;93(5):735-40. doi: 10.3324/haematol.12285. Epub 2008 Apr 2. Haematologica. 2008. PMID: 18387976

Cited by

• Stem cell donation--what advice can be given to the donor?

  Pamphilon D, Siddiq S, Brunskill S, Dorée C, Hyde C, Horowitz M, Stanworth S. Pamphilon D, et al. Br J Haematol. 2009 Oct;147(1):71-6. doi: 10.1111/j.1365-2141.2009.07832.x. Epub 2009 Aug 13. Br J Haematol. 2009. PMID: 19681886 Free PMC article. Review.

• Hematopoietic stem cell mobilization for gene therapy of adult patients with severe β-thalassemia: results of clinical trials using G-CSF or plerixafor in splenectomized and nonsplenectomized subjects.

  Yannaki E, Papayannopoulou T, Jonlin E, Zervou F, Karponi G, Xagorari A, Becker P, Psatha N, Batsis I, Kaloyannidis P, Tahynopoulou V, Constantinou V, Bouinta A, Kotta K, Athanassiadou A, Anagnostopoulos A, Fassas A, Stamatoyannopoulos G. Yannaki E, et al. Mol Ther. 2012 Jan;20(1):230-8. doi: 10.1038/mt.2011.195. Epub 2011 Sep 27. Mol Ther. 2012. PMID: 21952171 Free PMC article. Clinical Trial.

• Curing Hemoglobinopathies: Challenges and Advances of Conventional and New Gene Therapy Approaches.

  Motta I, Ghiaccio V, Cosentino A, Breda L. Motta I, et al. Mediterr J Hematol Infect Dis. 2019 Nov 1;11(1):e2019067. doi: 10.4084/MJHID.2019.067. eCollection 2019. Mediterr J Hematol Infect Dis. 2019. PMID: 31700592 Free PMC article. Review.

• Severe events in donors after allogeneic hematopoietic stem cell donation.

  Halter J, Kodera Y, Ispizua AU, Greinix HT, Schmitz N, Favre G, Baldomero H, Niederwieser D, Apperley JF, Gratwohl A. Halter J, et al. Haematologica. 2009 Jan;94(1):94-101. doi: 10.3324/haematol.13668. Epub 2008 Dec 4. Haematologica. 2009. PMID: 19059940 Free PMC article.

• Autologous Bone-Marrow vs. Peripheral Blood Mononuclear Cells Therapy for Peripheral Artery Disease in Diabetic Patients.

  Yunir E, Kurniawan F, Rezaprasga E, Wijaya IP, Suroyo I, Matondang S, Irawan C, Soewondo P. Yunir E, et al. Int J Stem Cells. 2021 Feb 28;14(1):21-32. doi: 10.15283/ijsc20088. Int J Stem Cells. 2021. PMID: 33377454 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley